Risk Factors for Community-Acquired Urinary Tract Infection Due to Quinolone-Resistant E. coli
Authors:
- 12 January 2008
- journal article
- Published by Springer Nature in Infection
- Vol. 36 (1) , 41-45
Abstract
Resistance to fluoroquinolone drugs is emerging among E. coli causing community acquired urinary tract infections (COMA-UTI). To evaluate demographic and clinical risk factors associated with COMA-UTI due to quinolone-resistant E. coli (QREc). In this case-control study, clinical and demographic data from 300 COMA-UTI due to E. coli (including 150 QREc) were analyzed. By univariate analysis QREc was associated to males, older patients, nursing home residents, functionally dependent, dementia, diabetes, cardiovascular diseases, immunosupression, nephrolithiasis, recurrent UTI, invasive procedures, hospitalization, and antibiotic use within previous 6 months. By multivariate analysis, use of ciprofloxacin (OR 20.6 [CI 2.3–179.2], p = 0.006) or ofloxacin (OR 7.5 [CI 2.9–19.4], p < 0.0001), previous invasive procedure (OR 6.6 [CI 3.0–14.7], p < 0.0001), recurrent UTI (OR 4.7 [CI 2.3–9.3], p < 0.0001), and previous hospitalization (OR 2.9 [CI 1.4–6], p = 0.003) were identified as independent risk factors for COMA-UTI due to QREc. In patients with one or more of the risk factors identified here, the empiric use of quinolones should be reconsidered.Keywords
This publication has 22 references indexed in Scilit:
- Risk factors for a poor outcome after therapy for acute pyelonephritisBJU International, 2006
- Fluoroquinolone-Resistant Urinary Isolates of Escherichia coli from Outpatients Are Frequently Multidrug Resistant: Results from the NorthAmerican Urinary Tract Infection Collaborative Alliance-QuinoloneResistance StudyAntimicrobial Agents and Chemotherapy, 2006
- In Vivo Selection of Fluoroquinolone-Resistant Escherichia coli Isolates Expressing Plasmid-Mediated Quinolone Resistance and Expanded-Spectrum β-LactamaseAntimicrobial Agents and Chemotherapy, 2006
- Effect of quinolone treatment on selection and persistence of quinolone-resistant Escherichia coli in swine faecal floraJournal of Applied Microbiology, 2005
- Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in TurkeyJournal of Antimicrobial Chemotherapy, 2005
- Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United StatesAntimicrobial Agents and Chemotherapy, 2002
- Empiric Use of Trimethoprim‐Sulfamethoxazole (TMP‐SMX) in the Treatment of Women with Uncomplicated Urinary Tract Infections, in a Geographical Area with a High Prevalence of TMP‐SMX–Resistant UropathogensClinical Infectious Diseases, 2002
- Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in PolandJournal of Antimicrobial Chemotherapy, 2001
- Mechanisms of Fluoroquinolone Resistance: An Update 1994-1998Drugs, 1999
- Risk Factors for Acquisition of Urinary Tract Infections Caused by Ciprofloxacin Resistant Escherichia ColiJournal of Urology, 1995